| Andrea Wait, MD | |
|
3901 Beaubien St, Detroit, MI 48201-2119 | |
| (313) 966-0254 | |
| Not Available |
| Full Name | Andrea Wait |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 3901 Beaubien St, Detroit, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033563101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4351037013 (Michigan) | Primary |
| Entity Name | University Pediatricians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811920549 PECOS PAC ID: 9638070568 Enrollment ID: O20040115000125 |
News Archive
Dr. Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University has published a report in the current issue of the American Journal of Medicine that obesity is becoming as big a hazard worldwide, comparable to cigarette smoking.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results. The Engenex Negative Pressure Wound Therapy (NPWT) system's Bio-Dome wound interface showed superior tensile strength and lower simulated bioadhesion when compared with GranuFoam (polyurethane foam).
Californians support health reform, a new polls says, even as Calif. Gov. Jerry Brown seeks a special session from state lawmakers to deal with health reform issues, which he says can go no further without more federal guidance.
Spirogen Ltd. a leading oncology-focused company developing DNA sequence targeted agents, announced a multi-year research collaboration and license agreement with Genentech, a member of the Roche Group.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Wait, MD 21458 Morningside Dr, Grosse Pointe Woods, MI 48236-1257 Ph: (313) 910-9841 | Andrea Wait, MD 3901 Beaubien St, Detroit, MI 48201-2119 Ph: (313) 966-0254 |
News Archive
Dr. Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University has published a report in the current issue of the American Journal of Medicine that obesity is becoming as big a hazard worldwide, comparable to cigarette smoking.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results. The Engenex Negative Pressure Wound Therapy (NPWT) system's Bio-Dome wound interface showed superior tensile strength and lower simulated bioadhesion when compared with GranuFoam (polyurethane foam).
Californians support health reform, a new polls says, even as Calif. Gov. Jerry Brown seeks a special session from state lawmakers to deal with health reform issues, which he says can go no further without more federal guidance.
Spirogen Ltd. a leading oncology-focused company developing DNA sequence targeted agents, announced a multi-year research collaboration and license agreement with Genentech, a member of the Roche Group.
› Verified 1 days ago
Dr. Ijeoma Nnodim Opara, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4201 St. Antoine Ste 6a & 6b, General Medicine Ambulatory Practice, Detroit, MI 48201 Phone: 313-745-4627 Fax: 313-966-7305 | |
Dr. Alissa M Martin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3901 Beaubien, Children's Hospital Of Mi, Detroit, MI 48201 Phone: 313-745-5515 Fax: 313-745-5237 | |
Norimitsu Kuwabara, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Children's Specialty Center, 3950 Beaubien, Detroit, MI 48201 Phone: 313-745-5906 Fax: 313-745-0955 | |
Karolina Maksimowski, Pediatrics Medicare: Medicare Enrolled Practice Location: 3901 Beaubien St, Detroit, MI 48201 Phone: 313-745-5260 Fax: 313-966-0665 | |
Raffat A. Siddiqi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Henry Ford Medical Group - Detroit Northwest, 7800 W Outer Drive, Detroit, MI 48235 Phone: 313-653-2500 Fax: 313-653-2555 | |
Dr. Rupa Thacker, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 3901 Beaubien St, Detroit, MI 48201 Phone: 313-745-5533 | |
Joshua Kim, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 3901 Beaubien St, Detroit, MI 48201 Phone: 313-745-5870 |